Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
Eli Lilly and Company
Rohit Loomba; Mark L Hartman; Eric J Lawitz; Raj Vuppalanchi; Jérôme Boursier; Elisabetta Bugianesi; Masato Yoneda; Cynthia Behling; Oscar W Cummings; Yuanyuan Tang; Bram Brouwers; Deborah A Robins; Amir Nikooie; Mathijs C Bunck; Axel Haupt; Arun J Sanyal; SYNERGY-NASH Investigators